Background Transoral robotic surgery (TORS) opens new perspectives. We evaluated the
outcomes for patients having undergone TORS after previous radiotherapy. Methods A …

Objectives: Overall treatment package time (from surgery to radiotherapy [RT] completion)>
100 days can portend poor outcomes in head and neck cancer. Faster postoperative …

Importance Large patient cohorts are necessary to validate the efficacy of transoral robotic
surgery (TORS) in the management of head and neck cancer. Objectives To review …

Background Transoral robotic surgery (TORS) is an emerging minimally invasive surgical
treatment for residual, recurrent, and new primary head and neck cancers in previously …

Abstract Objectives/Hypothesis: To evaluate the patterns of failure, survival, and functional
outcomes for patients treated with transoral robotic surgery (TORS) and compare these …

Background To date, this prospective cohort study is the largest of its kind from a single
European academic tertiary care center to report 2-year survival outcomes for head and …

Transoral robotic surgery (TORS) has been used for treating pharyngeal and laryngeal
cancers for many years. However, the application of neoadjuvant chemotherapy (NACT) …

Background Transoral robotic surgery (TORS) is now a well‐validated technique for
resection of head and neck cancers. Benefits include reduced patient morbidity, swallowing …

Transoral robotic assisted surgery (TORS) represents an innovative endoscopic therapeutic
alternative in the treatment of head and neck tumors. Many publications favor this surgery …

Background: Transoral robotic surgery (TORS) has existed for nearly a decade as a
treatment option for cancers of the upper aerodigestive tract. A number of Phase II clinical …